Mission
Publication of high quality, high impact, peer-reviewed research papers and books.
Helpful
We are available for any assistance 24X7.
Fast and Transparent
We process all manuscripts fast and transparently, without compromising the peer-review standard.
Great Prices
High quality and lowest price are our USPs.
About the Journal
Journal of Pharmaceutical Research International (ISSN: 2456-9119) is dedicated to publish high quality papers (Click here for Types of paper) in all areas of pharmaceutical Science including pharmaceutical drugs, community pharmacy, hospital pharmacy, clinical pharmacy, compounding pharmacy, consultant pharmacy, internet pharmacy, veterinary pharmacy, nuclear pharmacy, military pharmacy, pharmacy informatics, pharmaceutics, medicinal chemistry, pharmacognosy, pharmacotherapy, pharmacodynamics, pharmacokinetics, clinical pharmacology, neuropharmacology, psychopharmacology, pharmacogenetics, pharmacogenomics, pharmacoepidemiology, toxicology, theoretical pharmacology, posology, pharmacognosy, behavioral pharmacology, environmental pharmacology, medicine development and safety testing, drug legislation and safety, pharmaceutical microbiology, pharmaceutical molecular biology, pharmaceutical biotechnology. The journal also encourages the submission of useful reports of negative results. This is a quality controlled, OPEN peer reviewed, open access INTERNATIONAL journal.
Journal Info
Name: Journal of Pharmaceutical Research International
ISSN: 2456-9119
Past name: British Journal of Pharmaceutical Research
ISSN: 2231-2919 (past)
Frequency: 30 days
NLM ID: 101631759
Journal DOI: http://dx.doi.org/10.9734/jpri (Link)
Peer-review model: Advanced OPEN peer review
Index Copernicus: ICV: 100.00
Digital Archiving: Journal Repository (JR), LOCKSS, CLOCKSS
ISI MASTER JOURNAL LIST: (screen shot)
NAAS score (2020): 5.51
Emerging Sources Citation Index: (screen shot)
Latest Articles
Synthesis and Evaluation of Anticonvulsant Activity of Some Quinazoline Analogues
Case Report on: Dandy Walker Malformation Syndrome
Luteolin: A Potential Multiple Targeted Drug Effectively Inhibits Diabetes Mellitus Protein Targets
We encourage readers to sign up for the publishing notification service for this journal. Use the Register link at the top of the home page for the journal. This registration will result in the reader receiving the Table of Contents by email for each new issue of the journal. This list also allows the journal to claim a certain level of support or readership. See the journal's Privacy Statement, which assures readers that their name and email address will not be used for other purposes.
Interested in submitting to this journal? We recommend that you review the About the Journal page for the journal's section policies, as well as the Author Guidelines. Authors need to register with the journal prior to submitting or, if already registered, can simply log in and begin the five-step process.
We encourage research librarians to list this journal among their library's electronic journal holdings. As well, it may be worth noting that this journal's open source publishing system is suitable for libraries to host for their faculty members to use with journals they are involved in editing (see Open Journal Systems).